McPhadden Samac Tuovi

November 10, 2009 15:05 ET

Media Release: Evolence-Canadian Class Action

TORONTO, ONTARIO--(Marketwire - Nov. 10, 2009) - Toronto law firm McPhadden Samac Tuovi announced today that it has commenced a proposed class action against Johnson & Johnson and related companies relative to the injectable collagen dermal filler Evolence.

The Evolence claim involves people who were injected with Evolence and allegedly developed side effects that in some cases included disfiguring nodule formation. It is alleged that Johnson & Johnson and related companies failed to warn the public about the potential of these adverse effects.

The plaintiff is Mara Micevic of Oakville, Ontario. Ms. Micevic says that she was injected with Evolence to eliminate, or at least reduce, wrinkles around her mouth. She wanted to look better and instead ended up with painful and visible nodules in her lips. "It is almost three years since my injection and I am still suffering the painful effects," says Ms. Micevic.

Ms. Micevic says that she was not aware beforehand that Evolence might have this effect on her.

The claim is on behalf of all residents of Canada who were injected with Evolence and allege that they suffered injuries and damages.

The amount claimed is $15 million.

Zoran Samac, one of Ms. Micevic's lawyers, said "Manufacturers of beauty enhancement products owe a duty to warn the public of the potential dangers of their products so that it is possible to properly weigh the risks before using those products."

To view the statement of claim that accompanies this release, click the following link: http://media3.marketwire.com/docs/evolenceclaim.pdf.

Contact Information